Edwards Lifesciences Corp

Candriam S.C.A. EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

234,968

Value ($000)

20,032

Weight

0.1%

2019 Q3 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	20,032	0.1%	234,968	12/31/2025
2025 Q3	11/6/2025	4,821	0.0%	61,990	9/30/2025
2025 Q2	8/8/2025	4,574	0.0%	58,485	6/30/2025
2025 Q1	5/14/2025	4,106	0.0%	56,647	3/31/2025
2024 Q4	2/7/2025	9,304	0.1%	125,676	12/31/2024
2024 Q3	11/13/2024	8,396	0.0%	127,235	9/30/2024
2024 Q2	8/5/2024	18,503	0.1%	200,325	6/30/2024
2024 Q1	5/6/2024	4,746	0.0%	49,663	3/31/2024
2023 Q4	2/14/2024	3,654	0.0%	47,921	12/31/2023
2023 Q3	11/13/2023	8,227	0.1%	118,745	9/30/2023
2023 Q2	8/8/2023	18,398	0.1%	195,040	6/30/2023
2023 Q1	5/12/2023	20,087	0.1%	263,794	3/31/2023
2022 Q4	2/13/2023	20,149	0.1%	270,075	12/31/2022
2022 Q3	11/10/2022	40,513	0.3%	490,276	9/30/2022
2022 Q2	8/3/2022	18,052	0.1%	189,853	6/30/2022
2022 Q1	5/13/2022	20,696	0.1%	175,818	3/31/2022
2021 Q4	2/10/2022	19,891	0.1%	153,540	12/31/2021
2021 Q3	11/9/2021	13,013	0.1%	114,949	9/30/2021
2021 Q2	7/20/2021	11,691	0.1%	112,878	6/30/2021
2021 Q1	4/29/2021	8,429	0.1%	96,190	3/31/2021
2020 Q4	1/22/2021	8,776	0.1%	96,190	12/31/2020
2020 Q3	10/19/2020	6,965	0.1%	87,263	9/30/2020
2020 Q2	7/23/2020	6,485	0.1%	93,837	6/30/2020
2020 Q1	5/26/2020	7,438	0.1%	32,614	3/31/2020
2019 Q4	2/5/2020	7,609	0.1%	32,614	12/31/2019
2019 Q3	2/5/2020	6,744	0.1%	30,669	9/30/2019